Chance Pharma Secures NMPA Acceptance for CXG87 Respiratory Drug NDA
Chance Pharma secures National Medical Products Administration acceptance of NDA for CXG87, marking its first filing and a key step toward commercialisation of a novel respiratory therapy.
Chance Pharma | 08/05/2026 | By News Bureau
Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies
Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.
Chance Pharma | 18/03/2025 | By Aishwarya | 202
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy